These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32575598)

  • 41. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is waiting time a measure of access to liver transplantation? Is shorter necessarily better?
    Freeman RB
    Hepatology; 2007 Aug; 46(2):602-3. PubMed ID: 17661416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should we use liver grafts repeatedly refused by other transplant teams?
    Winter A; Landais P; Azoulay D; Disabato M; Compagnon P; Antoine C; Jacquelinet C; Daurès JP; Féray C
    JHEP Rep; 2020 Aug; 2(4):100118. PubMed ID: 32695966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
    Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
    Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rescue allocation for liver transplantation within Eurotransplant: the Heidelberg experience.
    Schemmer P; Nickkholgh A; Gerling T; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2009 Dec; 23 Suppl 21():42-8. PubMed ID: 19930316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
    Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
    Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HEPATOCELLULAR CARCINOMA PATIENTS ARE ADVANTAGED IN THE CURRENT BRAZILIAN LIVER TRANSPLANT ALLOCATION SYSTEM. A COMPETING RISK ANALYSIS.
    Rodríguez S; Fleck AM; Mucenic M; Marroni C; Brandão A
    Arq Gastroenterol; 2020; 57(1):19-23. PubMed ID: 32294731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Allocation systems in transplantation medicine: Advantages and disadvantages].
    Gottlieb J; Gwinner W; Strassburg CP
    Internist (Berl); 2016 Jan; 57(1):15-24. PubMed ID: 26782280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is MELD really the definitive score for liver allocation?
    Lladó L; Figueras J; Memba R; Xiol X; Baliellas C; Vázquez S; Ramos E; Torras J; Rafecas A; Fabregat J; Lama C; Jaurrieta E
    Liver Transpl; 2002 Sep; 8(9):795-8. PubMed ID: 12200780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience.
    Bruns H; Hillebrand N; Schneider T; Hinz U; Fischer L; Schmidt J; Goldschmidt AJ; Schemmer P
    Clin Transplant; 2011; 25(5):E558-65. PubMed ID: 21585550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for short- and long-term mortality in liver transplant recipients with MELD score ≥30.
    Kaltenborn A; Hartmann C; Salinas R; Ramackers W; Kleine M; Vondran FW; Barthold M; Lehner F; Klempnauer J; Schrem H
    Ann Transplant; 2015 Jan; 20():59-69. PubMed ID: 25630462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wait-list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry-based cohort.
    van der Doef HPJ; van Rheenen PF; van Rosmalen M; Rogiers X; Verkade HJ;
    Liver Transpl; 2018 Jun; 24(6):810-819. PubMed ID: 29377411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lung Transplantation in Germany Since the Introduction of the Lung Allocation Score.
    Gottlieb J; Smits J; Schramm R; Langer F; Buhl R; Witt C; Strueber M; Reichenspurner H
    Dtsch Arztebl Int; 2017 Mar; 114(11):179-185. PubMed ID: 28382903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.